What’s at stake in Samsung BioLogics accounting scandal?
Samsung BioLogics has come under pressure as the country’s financial authorities have claimed that the evaluation of its affiliate violated accounting rules. Dubbed as one of Samsung Group’s future growth engines, the contract drug-manufacturing firm has enjoyed blowout days with its stock price jumping nearly fivef...
Hyundai Motor named official sponsor of MLB World Tour in Seoul
S. Korea OKs Ansys' noncontrolling stake purchase in Humanetics
IKEA to invest $327 mln for expansion in S. Korea
HD Korea Shipbuilding wins W489.6b order for 3 ammonia carriers
Celltrion's new autoimmune disease treatment Zymfentra hits US market
Samsung C&T shareholders vote down activists' dividend hike proposal